SCHEMBL6067982

SCHEMBL6067982

Oc1ccc(-c2cccs2)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
RUNX1 Q01196 1/20 0.47
CBFB Q13951 1/20 0.47
RPS6KB2 Q9UBS0 1/20 0.47
ALOX5 P09917 1/20 0.47
TMIGD3 P0DMS9 2/20 0.45
ADORA2A P29274 2/20 0.45
ADORA1 P30542 2/20 0.45
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
QPCT Q16769 1/20 0.43
CHEK1 O14757 1/20 0.43
WEE1 P30291 1/20 0.43
ERN1 O75460 2/20 0.42
MEN1 O00255 1/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27752649 0.82 ESR2 (0.61) MAPTALDH1A1GAAESR1ESR2
SCHEMBL7157852 0.82 ESR1 (0.57) RPS6KB2TMIGD3ADORA2AADORA1ESR1
SCHEMBL14027112 0.82 RPS6KB2 (0.53) MAPTALDH1A1GAAHPGDRPS6KB2
SCHEMBL28165896 0.82 RPS6KB2 (0.44) MAPTALDH1A1GAAHPGDHTT
SCHEMBL5704962 0.80 RPS6KB2 (0.44) MAPTALDH1A1GAAHPGDRPS6KB2
SCHEMBL6068015 0.80 TMIGD3 (0.45) MAPTALDH1A1GAAHPGDRPS6KB2
SCHEMBL6764775 0.80 MAPT (0.46) MAPTRPS6KB2TMIGD3ADORA2AADORA1
SCHEMBL6257238 0.79 KCNH2 (0.50) MAPTALDH1A1GAAHPGDRPS6KB2
Hydrochloric Acid SCHEMBL5705099 0.79 RPS6KB2 (0.43) MAPTALDH1A1GAAHPGDRPS6KB2
SCHEMBL6067845 0.78 RPS6KB2 (0.55) MAPTALDH1A1GAAHPGDRPS6KB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100349886-C 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2007-11-21 CN claimed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US claimed
CN-1633426-A 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2005-06-29 CN claimed
EP-1392673-B1 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AG (DE) 2005-06-08 EP claimed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US claimed
CN-100349886-C 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2007-11-21 CN disclosed
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
CN-1633426-A 1, 3-dihydroxybenzene derivatives and coloring agents containing the same WELLA AG (US) 2005-06-29 CN disclosed
EP-1392673-B1 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AG (DE) 2005-06-08 EP disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 MAPT 1176/4885ALDH1A1 34/4885GAA 3269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.